INTRACRANIAL HEMORRHAGE DURING THE USE OF VENOVENOUS ECMO IN COVID 19: A CASE SERIES
Critical Care Medicine
; 50:138-138, 2022.
Article
in English
| Academic Search Complete | ID: covidwho-1597993
ABSTRACT
Despite ECMO being a valid option there have been reported complications possibly due to viral pathophysiology posing unique perturbations not seen in other cases of acute respiratory distress syndrome (ARDS). Deliberation of risks, benefits, and neurologic assessments prior to initiation of VVECMO in patients with COVID-19 ARDS needs to be taken. B Introduction/Hypothesis:
b The COVID-19 outbreak was declared a pandemic by the World Health Organization on March 11, 2020. [Extracted from the article] Copyright of Critical Care Medicine is the property of Lippincott Williams & Wilkins and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)
Full text:
Available
Collection:
Databases of international organizations
Database:
Academic Search Complete
Language:
English
Journal:
Critical Care Medicine
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS